Lv4
520 积分 2023-02-26 加入
Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension: The Single-Center, Prospective, First-in-Man PADN-1 Study (First-in-Man Pulmonary Artery Denervation for Treatment of Pulmonary Artery Hypertension)
6小时前
求助中
Management of Pulmonary Hypertension in the Context of Heart Failure with Preserved Ejection Fraction
7个月前
已完结
Use of Levosimendan in Patients with Pulmonary Hypertension: What is the Current Evidence?
7个月前
已完结
Unmasking right ventricular-arterial uncoupling during fluid challenge in pulmonary hypertension
8个月前
已完结
Advanced Hemodynamic and Cluster Analysis for Identifying Novel RV function subphenotypes in Patients with Pulmonary Hypertension
8个月前
已完结
Treatment effects of pulmonary artery denervation for pulmonary arterial hypertension stratified by REVEAL risk score: Results from PADN-CFDA trial
1年前
已完结
Pulmonary Artery Denervation Significantly Increases 6-Min Walk Distance for Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension Associated With Left Heart Failure: The PADN-5 Study
1年前
已完结
Pulmonary Artery Denervation as a New Therapeutic Option for Pulmonary Hypertension: A Systematic Review and Meta-Analysis
1年前
已完结
[Pulmonary artery denervation in pulmonary hypertension: physiological and clinical aspects]
1年前
已完结
The Evolution of Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension
1年前
已完结
皖公网安备34019202002308
